MedPath

Investigation of the efficacy of social contribution for patients with NAFLD to motivate to start and continue the treatment.

Not Applicable
Conditions
AFLD
Registration Number
JPRN-UMIN000020592
Lead Sponsor
Hamamatsu University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
33
Inclusion Criteria

Not provided

Exclusion Criteria

patient with other chronic liver disease. patient with pregnancy. Drug induced fatty liver patient with disease associated with fatty liver (polycystic ovary disease, hypothyroidism, obstructive sleep apnea syndrome, hypopituitarism, hypogonadism, after an operation of pancreaticoduodenectomy)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of NAFLD at 3 years after starting this intervention
Secondary Outcome Measures
NameTimeMethod
Improvement of ALT levels at 3 month after starting this intervention
© Copyright 2025. All Rights Reserved by MedPath